human | Q5 |
P496 | ORCID iD | 0000-0003-4717-1045 |
P3829 | Publons author ID | 2097822 |
P1053 | ResearcherID | J-3017-2017 |
P1153 | Scopus author ID | 18038126000 |
P108 | employer | University of Granada | Q1232180 |
P734 | family name | Rivera | Q24731165 |
Rivera | Q24731165 | ||
Rivera | Q24731165 | ||
P735 | given name | Margarita | Q6760124 |
Margarita | Q6760124 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q60472145 | A Cross-Sectional Study on the Prevalence and Risk Correlates of Mental Disorders |
Q35530520 | A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder |
Q40397660 | An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype |
Q55128222 | Analysis of shared heritability in common disorders of the brain |
Q40839651 | Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression |
Q57515292 | Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank |
Q92116731 | Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study |
Q47813318 | Body mass index, but not FTO genotype or major depressive disorder, influences brain structure |
Q34589883 | Comorbid medical illness in bipolar disorder |
Q57428733 | Depressive disorder moderates the effect of the FTO gene on body mass index |
Q36213137 | Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression |
Q58039526 | Erratum: The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression |
Q35711708 | Familiality and SNP heritability of age at onset and episodicity in major depressive disorder |
Q33601878 | Genetic effects influencing risk for major depressive disorder in China and Europe |
Q35023117 | Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study |
Q36542738 | Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it? |
Q37603806 | Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium |
Q63433066 | Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts |
Q42376263 | Genome-wide assessment of Parkinson's disease in a Southern Spanish population |
Q52560096 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. |
Q37611740 | Genome-wide association analysis of copy number variation in recurrent depressive disorder. |
Q63433064 | Genome-wide association study identifies 30 loci associated with bipolar disorder. |
Q51562429 | Genome-wide association study of major recurrent depression in the U.K. population. |
Q115209637 | Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology |
Q45817101 | Genome-wide searches for bipolar disorder genes |
Q57697186 | Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes |
Q34656699 | High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample |
Q37223293 | Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis |
Q39392604 | Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals |
Q45758985 | Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution |
Q38149476 | Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review. |
Q30412070 | Molecular signatures of major depression |
Q37952823 | Pharmacogenetics of response to antipsychotics in patients with schizophrenia |
Q36498543 | Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder |
Q92880012 | Physical exercise and body mass index as correlates of major depressive disorder in community-dwelling adults: Results from the PISMA-ep study |
Q36583679 | Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. |
Q39758102 | Polymorphic variation at the serotonin 1-A receptor gene is associated with comorbid depression and generalized anxiety |
Q48014228 | Protocol and methodology of Study epidemiological mental health in Andalusia: PISMA-ep. |
Q58726772 | Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis |
Q33827099 | Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study |
Q53247749 | The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. |
Q35754740 | The interaction between stress and genetic factors in the etiopathogenesis of depression |
Q48288210 | The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. |
Q57313488 | The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort |
Q35536875 | The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study |
Q35994785 | The successful search for genetic loci associated with depression |
Q57709293 | Variabilidad en el gen COMT y modificación del riesgo de esquizofrenia conferido por consumo de cannabis |
Search more.